Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.02 0.93% 2.18 531,279 12:13:37
Bid Price Offer Price High Price Low Price Open Price
2.16 2.20 2.18 2.16 2.16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 3.14 -0.24 -0.07 9
Last Trade Time Trade Type Trade Size Trade Price Currency
17:08:52 O 140,000 2.18 GBX

Byotrol (BYOT) Latest News

More Byotrol News
Byotrol Takeover Rumours

Byotrol (BYOT) Share Charts

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart

Intraday Byotrol Chart

Intraday Byotrol Chart

Byotrol (BYOT) Discussions and Chat

Byotrol Forums and Chat

Date Time Title Posts
31/7/201823:54Byotrol (BYOT) One to Watch on Wednesday -
27/2/201619:04Byotrol:::::::::Cleaning Up45
03/1/201309:22Byotrol - ready to tap a $5.6billion market?3,489

Add a New Thread

Byotrol (BYOT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-07-19 16:08:522.18140,0003,052.00O
2019-07-19 15:06:052.03140,0002,842.00O
2019-07-19 11:11:172.1738,837843.54O
2019-07-19 08:32:212.17100,0002,172.00O
2019-07-19 08:18:102.17112,4422,439.99O
View all Byotrol trades in real-time

Byotrol (BYOT) Top Chat Posts

Byotrol Daily Update: Byotrol Plc is listed in the Chemicals sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 2.16p.
Byotrol Plc has a 4 week average price of 1.96p and a 12 week average price of 1.96p.
The 1 year high share price is 4.10p while the 1 year low share price is currently 1.50p.
There are currently 402,836,491 shares in issue and the average daily traded volume is 649,867 shares. The market capitalisation of Byotrol Plc is £8,781,835.50.
mudbath: Unusually,one could not trade BYOT with Spreadex today. I am very optimistic that we might see some more upward movement in the share price early next week.
mudbath: I thought that their headline summary was,"alarming",whilst I see no evidence of the Byotrol share price,"going down the toilet"! Proactive's opportunistic and shallow view enabled substantial quantities of shares to be removed from the gullible at regrettably low prices.
mudbath: Byotrol 24 continues to churn out remarkable content on its US orientated Facebook pages. Generating a stream of proactive input of this quality takes talent. What an opportunity Byotrol,here in the UK,are passing up by not incorporating these eye catching promotions into their own blogs,twitter feed, etc. At least Medimark are "bigging up" their achievements on an almost daily basis. The BYOT share price looks poised to move significantly higher.
mudbath: Thanks for your views rocket fuel. A little research would reveal that Byotrol "has never been in a stronger and more exciting position." Far from the Byotrol share price revisiting 2p,I think you will swiftly find that this turns out to be merely wishful thinking on your part; for there is currently deep underlying demand for BYOT stock.
mudbath: A significant 928,089 delayed buy trade underlines my current view that the BYOT share price could well swiftly move above 3 pence and beyond. Byotrol's engagement of Alex Espalin (Ex product launch man at Kimberly-Clark Corporation)looks to be inspired,having regard to the speed with which he has overseen the EPA approval being gained and the introduction of Byotrol 24 across a growing number of TARGET stores,not to mention his stimulating the interest of other retailers in the product. This compares extremely favourably with Tristel's similar US endevours where they have spent 5 YEARS gaining EPA regulatory approval,only to issue the following statement alongside last weeks Interim Results :- "Furthermore, we have decided that our most prudent approach is to postpone commercialising the EPA approvals already obtained for our Duo and Jet products until we have greater visibility of the way ahead for the FDA project."..... "Conferring with consultants, peer companies and industry experts, we are led to believe that we should not be dismayed by the time it has taken to reach the point we are at today; nor by the cumulative cost, which amounted at 31 December 2018 to GBP1.3m." Byotrol/Medimark Scientific look poised to make inroads into Tristel's markets. Happy days !
mudbath: Investing is all about timing and if anyone missed the opportunity to mop up those Ruffer shares @ just 1.50 pence then fear not,for BYOT remain a total steal at today's 2.40 pence to buy.Remember that Medimark Scientific was purchased with Byotrol shares valued at 4.10 pence and with cash,also raised @ 4.0 pence. Listening to the vibes it looks as though BYOT are on something of a roll at the moment,with the market due to be appraised of progress in an upcoming trading update. It seems logical,to me,that the BYOT share price will soon resume its upward trajectory;maybe even in a vigorous fashion. BUY. NOW !!
mudbath: It looks as though the BYOT share price is about to move back towards fair value at a rate of knots, now that Ruffer have curtailed the recent dumping of the majority of their holding at that ludicrous 1.55 pence level. Nevertheless, Ruffer still hold 21 million shares,which could yet lead to future weakness if they intend to fully exit their position.
sikhthetech: They announced in July that Byotrol was on Trial from "Target is one of the largest mass market retailers in the US and our surface sanitiser is now on trial in 10% of their stores (from July 2018) under the brand 'Byotrol24'." and have said that the trial was extended beyond the initial 10 week period... "Now under trial under the brand 'Byotrol24' in US mass merchandiser Target. Trial now extended beyond the initial 10 week expected period." It's now over 20weeks... Are the products supplied for the trial on SoR basis? How much is it costing Target/Byotrol?
mudbath: Ruffer now down to a 9% holding(39,212,862) in Byotrol, according to today's RNS. The MMs have nudged up the bid to 2.28 pence. Since the finals, covering the trading period to March 31st,were released on August 23rd,the BYOT Directors have purchased over 2 million additional shares.With the ensuing six month trading period concluded on Sept 30th,the BOD will have enjoyed much clearer picture as to how the business is evolving. If the Interims,when presented next month, are deemed to be at all promising,then Ruffer should be able to shift, fairly swiftly,any remaining, unrequired Byotrol shares. (Should they not have been disposed of in the intervening period) Byotrol shares do look to be an interesting investment opportunity at the current 2.30 pence ask.
mudbath: After all,the conclusion of Byotrol's interim report read, "The recent fund raising of £4.6m, net of expenses, has given us the financial resources to grow and has secured some first-class new investors on our shareholder register. Our challenge now is to execute the commercial plan and deliver to the financial targets. The team is confident it will do so and looks forward to substantial progress in the second half of the financial year. We continue to look to our long-term future with confidence and excitement." The perverse market reaction to this most positive of statements was to take the BYOT share price down to its lowest ever level. It looks as though the market is now reconsidering the potential for Byotrol to shed its status as a "jam tomorrow company";hence the initial start of an upward movement in the SP,which might just evolve into an upward re rating of some significance.
Byotrol share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190720 08:00:27